Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan Lerner

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Translational Oncology|March 26, 2020
Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft ModelMichelle Zalles, Nataliya Smith, Debra Saunders, et al.
Gene|June 20, 2024
Contribution of circulating Mfge8 to human T2DM and cardiovascular diseaseMadhusmita Rout, Megan W Malone-Perez, Gilseung Park, et al.
Free Radical Biology & Medicine|June 30, 2015
OKN-007 decreases free radical levels in a preclinical F98 rat glioma modelPatricia Coutinho de Souza, Nataliya Smith, Oluwatomisin Atolagbe, et al.
JCI Insight|March 28, 2020
Control of PTH secretion by the TRPC1 ion channelMarta Onopiuk, Bonnie Eby, Vasyl Nesin, et al.
ACS Nano|February 13, 2023
Multifunctional Microgel-Based Cream Hydrogels for Postoperative Abdominal Adhesion PreventionBo Liu, Yunfan Kong, Olawale A Alimi, et al.
Plos One|August 7, 2020
Serum discrimination and phenotype assessment of coronary artery disease patents with and without type 2 diabetes prior to coronary artery bypass graft surgeryJames R Hocker, Megan Lerner, Stan A Lightfoot, et al.
Urology|March 17, 2018
Preclinical Animal Studies of Intravesical Recombinant Human Proteoglycan 4 as a Novel Potential Therapy for Diseases Resulting From Increased Bladder PermeabilityBeverley Greenwood-Van Meerveld, Ehsan Mohammadi, Rocco Latorre, et al.
Cancer Research|February 3, 2011
DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanismSripathi M Sureban, Randal May, Stan A Lightfoot, et al.
Journal of Cellular and Molecular Medicine|December 22, 2019
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse modelMichelle Zalles, Nataliya Smith, Jadith Ziegler, et al.
Neuro-Oncology|July 16, 2016
ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma modelsJadith Ziegler, Richard Pody, Patricia Coutinho de Souza, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Translational Oncology|March 26, 2020
Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft ModelMichelle Zalles, Nataliya Smith, Debra Saunders, et al.
Gene|June 20, 2024
Contribution of circulating Mfge8 to human T2DM and cardiovascular diseaseMadhusmita Rout, Megan W Malone-Perez, Gilseung Park, et al.
Free Radical Biology & Medicine|June 30, 2015
OKN-007 decreases free radical levels in a preclinical F98 rat glioma modelPatricia Coutinho de Souza, Nataliya Smith, Oluwatomisin Atolagbe, et al.
JCI Insight|March 28, 2020
Control of PTH secretion by the TRPC1 ion channelMarta Onopiuk, Bonnie Eby, Vasyl Nesin, et al.
ACS Nano|February 13, 2023
Multifunctional Microgel-Based Cream Hydrogels for Postoperative Abdominal Adhesion PreventionBo Liu, Yunfan Kong, Olawale A Alimi, et al.
Plos One|August 7, 2020
Serum discrimination and phenotype assessment of coronary artery disease patents with and without type 2 diabetes prior to coronary artery bypass graft surgeryJames R Hocker, Megan Lerner, Stan A Lightfoot, et al.
Urology|March 17, 2018
Preclinical Animal Studies of Intravesical Recombinant Human Proteoglycan 4 as a Novel Potential Therapy for Diseases Resulting From Increased Bladder PermeabilityBeverley Greenwood-Van Meerveld, Ehsan Mohammadi, Rocco Latorre, et al.
Cancer Research|February 3, 2011
DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanismSripathi M Sureban, Randal May, Stan A Lightfoot, et al.
Journal of Cellular and Molecular Medicine|December 22, 2019
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse modelMichelle Zalles, Nataliya Smith, Jadith Ziegler, et al.
Neuro-Oncology|July 16, 2016
ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma modelsJadith Ziegler, Richard Pody, Patricia Coutinho de Souza, et al.
Pageof 5